These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 23990088

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.
    Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654
    [Abstract] [Full Text] [Related]

  • 3. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM, Badizadegan ND.
    Risk Anal; 2017 Jun 31; 37(6):1109-1131. PubMed ID: 28561947
    [Abstract] [Full Text] [Related]

  • 4. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ, Robertson PW, Whybin LR.
    Med J Aust; 1994 Apr 18; 160(8):478-82. PubMed ID: 8170422
    [Abstract] [Full Text] [Related]

  • 5. A benefit-cost analysis of two-dose measles immunization in Canada.
    Pelletier L, Chung P, Duclos P, Manga P, Scott J.
    Vaccine; 1998 Apr 18; 16(9-10):989-96. PubMed ID: 9682349
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The German National Verification Committee for Measles and Rubella Elimination].
    Matysiak-Klose D, Razum O.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep 18; 56(9):1293-6. PubMed ID: 23990092
    [Abstract] [Full Text] [Related]

  • 9. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH, Eckhoff P, Cheng A, Hoff NA, Mukadi P, Shidi C, Gerber S, Wemakoy EO, Muyembe-Tafum JJ, Kominski GF, Rimoin AW.
    Vaccine; 2017 Oct 27; 35(45):6187-6194. PubMed ID: 28966000
    [Abstract] [Full Text] [Related]

  • 10. Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions.
    Thompson KM, Odahowski CL.
    Risk Anal; 2016 Jul 27; 36(7):1297-314. PubMed ID: 25545778
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.
    Tohme RA, Francois J, Cavallaro KF, Paluku G, Yalcouye I, Jackson E, Wright T, Adrien P, Katz MA, Hyde TB, Faye P, Kimanuka F, Dietz V, Vertefeuille J, Lowrance D, Dahl B, Patel R.
    Am J Trop Med Hyg; 2017 Oct 27; 97(4_Suppl):28-36. PubMed ID: 29064356
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ, Adhikary G, Ali MW, Ahmed S, Shamsuzzaman M, Odell C, Hashiguchi L, Lim SS, Alam N.
    BMC Infect Dis; 2016 Aug 12; 16():411. PubMed ID: 27519586
    [Abstract] [Full Text] [Related]

  • 18. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
    Uzicanin A, Zhou F, Eggers R, Webb E, Strebel P.
    Vaccine; 2004 Sep 03; 22(25-26):3419-26. PubMed ID: 15308367
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.